Accenture plc vs Pfizer Inc.
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Accenture plc (ACN) carries a "Neutral" signal with +8.3% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Technology and Healthcare sectors.
| Metric | Accenture plc (ACN) | Pfizer Inc. (PFE) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $18.0B | $14.5B |
| Revenue Growth | 8.3%* | -18.4% |
| Latest EPS | $2.93* | $0.47 |
| EPS Growth | 3.9%* | -39.7% |
| Sector | Technology | Healthcare |
| Quarters Tracked | 8 | 8 |
Accenture plc (ACN) carries a "Neutral" signal with +8.3% revenue growth, while Pfizer Inc. (PFE) is "Neutral" with -18.4% revenue growth. Both companies report in the Technology and Healthcare sectors.
Explore More
The side-by-side above pulls the SEC EDGAR 8-K filings data for both entity A and entity B. What follows is the interpretation — which specific axes carry the most weight for entity A versus entity B, and which differences are large enough to influence a real decision.
Practical use of the comparison: read the data above, then drill into the individual entity A and entity B detail pages for the underlying breakdown. A pairwise comparison answers the relative question; the per-entity pages answer the absolute question.
Source: SEC EDGAR 10-K filings, 2026.